Thus, it is evident that OSA can promote the formation and progression of AD biomarkers of Aβ and P-tau, which underlying mechanisms, are however not fully elucidated, let alone the impact of different degrees of OSA on AD biomarkers. The gene discussed is MAPT; the disease is Alzheimer disease.